Intracellular ATP and total adenylate concentrations are critical predictors of reovirus productivity from vero cells

Biotechnology and Bioengineering

Volumn 94, Issue 4, 2006, Pages 667-679

  Burgener, A ^a   Coombs, K ^a   Butler, M ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Adenylate; ATP; Energy charge; Reovirus; Vero

Indexed keywords

ADENOSINETRIPHOSPHATE; CELL CULTURE; CELLS; GROWTH KINETICS; REGRESSION ANALYSIS;

ADENYLATE; ADENYLATE ENERGY CHARGE (AEC); ENERGY CHARGE; REOVIRUS; VERO; VIRAL PRODUCTION;

VIRUSES;

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUTAMINE; NUCLEOTIDE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; ENERGY ABSORPTION; ENERGY CONSUMPTION; GROWTH CURVE; NONHUMAN; PREDICTION; REGRESSION ANALYSIS; REOVIRUS; VACCINE PRODUCTION; VERO CELL; VIRUS INFECTION;

ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELL DIVISION; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CULTURE MEDIA; GENES, REPORTER; GLUTAMINE; KINETICS; LUCIFERASES; REOVIRIDAE; VERO CELLS;

MAMMALIAN ORTHOREOVIRUS 3; REOVIRUS SP.;

EID: 33745761915     PISSN: 00063592     EISSN: 10970290     Source Type: Journal    
DOI: 10.1002/bit.20873     Document Type: Article

References (57)

1. Asher DM. 1999. Bovine sera used in the manufacture of biologicals: Current concerns and policies of the U.S. Food and Drug Administration regarding the transmissible spongiform encephalopathies. Dev Biol Stand 99:41-44.
2. Atkinson DE. 1968. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 7(11):4030-4034.
3. Ball LA. 2001. Replication strategies of RNA viruses. In: Knipe DM, Howley PM, editors. Fundamental virology. Philadelphia: Lippincott Williams and Wilkins. p 105-118.
4. Ball WJ, Jr., Atkinson DE. 1975. Adenylate energy charge in Saccharomyces cerevisiae during starvation. J Bacteriol 121(3):975-982.
5. Barnabe N, Butler M. 1998. The relationship between intracellular UDP-N-acetyl hexosamine nucleotide pool and monoclonal antibody production in a mouse hybridoma. J Biotechnol 60(1-2):67-80.
6. Beale AJ. 1992. Hazards of vaccine production. FEMS Microbiol Lett 79 (1-3):469-473.
7. Berry JM, Barnabe N, Coombs KM, Butler M. 1999. Production of reovirus type-1 and type-3 from Vero cells grown on solid and macroporous microcarriers. Biotechnol Bioeng 62(1):12-19.
8. Butler M, Jenkins H. 1989. Nutritional aspects of the growth of animal cells in culture. J Biotechnol 12:97-110.
9. Butler M, Burgener A, Patrick M, Berry M, Moffatt D, Huzel N, Barnabe N, Coombs K. 2000. Application of a serum-free medium for the growth of Vero cells and the production of reovirus. Biotechnol Prog 16(5):854-858.
10. Chandran K, Nibert ML. 2003. Animal cell invasion by a large nonenveloped virus: Reovirus delivers the goods. Trends Microbiol 11(8):374-382.
11. Chapman AG, Atkinson DE. 1973. Stabilization of adenylate energy charge by the adenylate deaminase reaction. J Biol Chem 248(23):8309-8312.
12. Chillakuru RA, Ryu DD, Yilma T. 1991. Propagation of recombinant vaccinia virus in HeLa cells: Adsorption kinetics and replication in batch cultures. Biotechnol Prog 7(2):85-92.
13. Coffey MC, Strong JE, Forsyth PA, Lee PW. 1998. Reovirus therapy of tumors with activated Ras pathway [see comments]. Science 282 (5392):1332-1334.
14. Coombs KM. 1996. Identification and characterization of a double-stranded RNA- reovirus temperature-sensitive mutant defective in minor core protein mu2. J Virol 70(7):4237-4245.
15. Coombs KM, Mak SC, Petrycky-Cox LD. 1994. Studies of the major reovirus core protein sigma 2: Reversion of the assembly-defective mutant tsC447 is an intragenic process and involves back mutation of Asp-383 to Asn. J Virol 68(1):177-186.
16. DiMaio D, Coen DM. 2001. Replication strategies of DNA viruses. In: Knipe DM, Howley PM, editors. Fundamental virology. Philadelphia: Lippincott Williams and Wilkins. p 119-131.
17. Edwards K, Urban J, Schreiber G. 1979. Relationship between protein synthesis and secretion in liver cells and the state of the adenine nucleotide system. Aust J Biol Sci 32(3):299-307.
18. el-Karamany RM. 1987. Production in Vero cells of an inactivated rabies vaccine from strain FRV/K for animal and human use. Acta Virol 31(4):321-328.
19. Estes MK. 2001. Rotaviruses and their replication. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins. p 1747-1785.
20. Hardie DG, Hawley SA. 2001. AMP-activated protein kinase: The energy charge hypothesis revisited. Bioessays 23(12):1112-1119.
21. Hardie DG, Salt IP, Hawley SA, Davies SP. 1999. AMP-activated protein kinase: An ultrasensitive system for monitoring cellular energy charge. Biochem J 338(Pt 3):717-722.
22. Hirasawa K, Nishikawa SG, Norman KL, Coffey MC, Thompson BG, Yoon CS, Waisman DM, Lee PW. 2003. Systemic reovirus therapy of metastatic cancer in immune-competent mice. Cancer Res 63(2):348-353.
23. Jung S, Behie LA, Lee PW, Farrell PJ. 2004. Optimization of reovirus production from mouse L-929 cells in suspension culture. Biotechnol Bioeng 85(7):750-760.
24. Kadam VD, Paranjape SP, Gangodkar SV, Deolankar RP. 1995. Nutrient composition for cultivation of Japanese encephalitis virus in vitro. Acta Virol 39(5-6):287-289.
25. Kannan K, Jain SK. 1994. Effect of high glucose on cellular proliferation and lipid peroxidation in cultured Vero cells. Horm Metab Res 26(7):322-325.
26. Kapikian AZ, Hoshino Y, Chanock RM. 2001. Rotaviruses. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins. p 1787-1833.
27. Lang DR, Glass RI, Compans RW. 1996. Summary of the Fifth Rotavirus Vaccine Workshop, J Infect Dis 174(Suppl 1):S3-S4.
28. Leone G, Coffey MC, Gilmore R, Duncan R, Maybaum L, Lee PW. 1996. C-terminal trimerization, but not N-terminal trimerization, of the reovirus cell attachment protein is a posttranslational and Hsp70/ATP-dependent process. J Biol Chem 271(14):8466-8471.
29. Live TR, Kaminskas E. 1975. Changes in adenylate energy charge in Ehrlich ascites tumor cells deprived of serum, glucose, or amino acids. J Biol Chem 250(5):1786-1789.
30. Lundin A. 2000. Use of firefly luciferase in ATP-related assays of biomass, enzymes, and metabolites. Methods Enzymol 305:346-370.
31. Mann GF, de Mucha Macias J. 1976. A perfusion culture system for virus vaccine manufacture in diploid cell cultures. Bull Pan Am Health Organ 10(3):205-211.
32. McTaggart S, Al-Rubeai M. 2001. Relationship between cell proliferation, cell-cycle phase, and retroviral vector production in FLYRD18 human packaging cells. Biotechnol Bioeng 76(1):52-60.
33. Merten OW. 2004. State-of-the-art of the production of retroviral vectors. J Gene Med 6(Suppl 1):S105-S124.
34. Merten OW, Manuguerra JC, Hannoun C, van der Werf S. 1999. Production of influenza virus in serum-free mammalian cell cultures. Dev Biol Stand 98:23-37.
35. Montagnon BJ, Vincent-Falquet JC, Saluzzo JF. 1999. Experience with Vero cells at Pasteur Merieux Connaught. Dev Biol Stand 98:137-140.
36. Mukhopadhyay A, Mukhopadhyay SN, Talwar GP. 1994. Physiological factors of growth and susceptibility to virus regulating Vero cells for optimum yield of vaccinia and cloned gene product (beta-hCG). J Biotechnol 36(2):177-182.
37. Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, Zanardi LR, Setia S, Fair E, LeBaron CW, Wharton M, Livengood JR. 2001. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med 344(8):564-572.
38. Nadeau I, Gamier A, Côté J, Massie B, Chavarie C, Kamen A. 1996. Improvement of recombinant protein production with the human adenovirus/293S expression system using fed-batch strategies. Biotechnol Bioeng 51:613-623.
39. Nadeau I, Gilbert PA, Jacob D, Perrier M, Kamen A. 2002. Low-protein medium affects the 293SF central metabolism during growth and infection with adenovirus. Biotechnol Bioeng 77(1):91-104.
40. Nibert ML, Schiff LA. 2001. Reoviruses and their replication. In: Knipe DM, Howley PM, editor. Fields virology. Philadelphia: Lippincott Williams & Wilkins. p 1679-1728.
41. Nibert ML, Margraf RL, Coombs KM. 1996. Nonrandom segregation of parental alleles in reovirus reassortants. J Virol 70(10):7295-7300.
42. Noble S, Nibert ML. 1997. Characterization of an ATPase activity in reovirus cores and its genetic association with core-shell protein lambda1. J Virol 71(3):2182-2191.
43. Norman KL, Coffey MC, Hirasawa K, Demetrick DJ, Nishikawa SG, DiFrancesco LM, Strong JE, Lee PW. 2002. Reovirus oncolysis of human breast cancer. Hum Gene Ther 13(5):641-652.
44. Patterson MK, Jr. 1979. Measurement of growth and viability of cells in culture. Methods Enzymol 58:141-152.
45. Roy P. 2001. Orbiviruses. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins. p 1835-1869.
46. Ryll T, Wagner R. 1991. Improved ion-pair high-performance liquid chromatographic method for the quantification of a wide variety of nucleotides and sugar-nucleotides in animal cells. J Chromatogr 570(1):77-88.
47. Ryll T, Wagner R. 1992. Intracellular ribonucleotide pools as a tool for monitoring the physiological state of in vitro cultivated mammalian cells during production processes. Biotechnol Bioeng 40:934-946.
48. Shatkin AJ, Kozak M. 1983. Biochemical aspects of reovirus transcription and translation. In: Joklik WK, editor. The Reoviridae. New York: Plenum Publishing Corp. p 79-106.
49. Shevitz J, LaPorte TL, Stinnett TE. 1990. Production of viral vaccines in stirred bioreactors. Adv Biotechnol Processes 14:1-35.
50. Swedes JS, Sedo RJ, Atkinson DE. 1975. Relation of growth and protein synthesis to the adenylate energy charge in an adenine-requiring mutant of Escherichia coli. J Biol Chem 250(17):6930-6938.
51. Tattersall P. 1972. Replication of the parvovirus MVM. I. Dependence of virus multiplication and plaque formation on cell growth. J Virol 10(4):586-590.
52. Tyler KL. 2001. Mammalian reoviruses. In: Knipe DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams & Wilkins. p 1729-1745.
53. Walker-Simmons M, Atkinson DE. 1977. Functional capacities and the adenylate energy charge in Escherichia coli under conditions of nutritional stress. J Bacteriol 130(2):676-683.
54. WHO. 1987. Acceptability of cell substrates for production of biologicals. Report of a WHO Study Group on Biologicals. World Health Organ Tech Rep Ser 747:1-29.
55. Wolter S, Richards R, Armentrout RW. 1980. Cell cycle-dependent replication of the DNA of minute virus of mice, a parvovirus. Biochim Biophys Acta 607(3):420-431.
56. Wu SC, Liu CC, Lian WC. 2004. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development. Vaccine 22(29-30):3858-3864.
57. Yoshino M, Murakami K. 1981. In situ studies on AMP deaminase as a control system of the adenylate energy charge in yeasts. Biochim Biophys Acta 672(1):16-20.